256 related articles for article (PubMed ID: 16380106)
1. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
2. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis.
Rajeshkumar NV; Pillai MR; Kuttan R
J Exp Clin Cancer Res; 2003 Jun; 22(2):201-12. PubMed ID: 12866570
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Agarwal B; Bhendwal S; Halmos B; Moss SF; Ramey WG; Holt PR
Clin Cancer Res; 1999 Aug; 5(8):2223-9. PubMed ID: 10473109
[TBL] [Abstract][Full Text] [Related]
7. Potential antitumor effects of statins (Review).
Jakobisiak M; Golab J
Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
[TBL] [Abstract][Full Text] [Related]
8. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
Feleszko W; Mlynarczuk I; Balkowiec-Iskra EZ; Czajka A; Switaj T; Stoklosa T; Giermasz A; Jakóbisiak M
Clin Cancer Res; 2000 May; 6(5):2044-52. PubMed ID: 10815931
[TBL] [Abstract][Full Text] [Related]
10. The statins as anticancer agents.
Chan KK; Oza AM; Siu LL
Clin Cancer Res; 2003 Jan; 9(1):10-9. PubMed ID: 12538446
[TBL] [Abstract][Full Text] [Related]
11. The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide.
Bardeleben RV; Dunkern T; Kaina B; Fritz G
Int J Mol Med; 2002 Oct; 10(4):473-9. PubMed ID: 12239596
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity.
Hirabayashi K; Yano J; Inoue T; Yamaguchi T; Tanigawara K; Smyth GE; Ishiyama K; Ohgi T; Kimura K; Irimura T
Cancer Res; 1999 Sep; 59(17):4325-33. PubMed ID: 10485480
[TBL] [Abstract][Full Text] [Related]
13. The effect of lovastatin on [3H]thymidine uptake in HTC-4 and LLC-L1 tumor cells.
Morris TJ; Palm SL; Furcht LT; Buchwald H
J Surg Res; 1996 Mar; 61(2):367-72. PubMed ID: 8656610
[TBL] [Abstract][Full Text] [Related]
14. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
Sarna S; Bhola RK
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
[TBL] [Abstract][Full Text] [Related]
15. Proteomics to display lovastatin-induced protein and pathway regulation in rat liver.
Steiner S; Gatlin CL; Lennon JJ; McGrath AM; Aponte AM; Makusky AJ; Rohrs MC; Anderson NL
Electrophoresis; 2000 Jun; 21(11):2129-37. PubMed ID: 10892724
[TBL] [Abstract][Full Text] [Related]
16. Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase.
Mattingly RR; Gibbs RA; Menard RE; Reiners JJ
J Pharmacol Exp Ther; 2002 Oct; 303(1):74-81. PubMed ID: 12235235
[TBL] [Abstract][Full Text] [Related]
17. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
Roboz J; Jiang J; Holland JF; Bekesi JG
Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor activity of tumor necrosis factor-alpha and lovastatin against MmB16 melanoma in mice.
Feleszko W; Lasek W; Gołab J; Jakóbisiak M
Neoplasma; 1995; 42(2):69-74. PubMed ID: 7617079
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.
Thibault A; Samid D; Tompkins AC; Figg WD; Cooper MR; Hohl RJ; Trepel J; Liang B; Patronas N; Venzon DJ; Reed E; Myers CE
Clin Cancer Res; 1996 Mar; 2(3):483-91. PubMed ID: 9816194
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin induces apoptosis in malignant mesothelioma cells.
Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
